The Regulation of C1 Activation and Its Role in Disease

C. Erik Hack
Humana Press, Totowa, NJ 33 -56

2000
Immunogenicity assessment of recombinant human c1-inhibitor: an integrated analysis of clinical studies.

Anurag Relan , Aartie Baboeram , Maurice Mannesse , Beatrijs Oortwijn
BioDrugs 26 ( 5) 303 -313

18
2012
Cytokine patterns during dengue shock syndrome

Tatty E. Setiati , Jos W. M. van der Meer , C. Erik Hack , Catharina Suharti
European Cytokine Network 14 ( 3) 172 -177

50
2003
DIFFERENTIAL EFFECT OF DONOR-SPECIFIC HLA ANTIBODIES IN LIVING VERSUS DECEASED DONOR KIDNEY TRANSPLANTATION

Frans H. J. Claas , M. C. Verhaar , Dave L. Roelen , Arjan van Zuilen
HLA 89 ( 6) 348 -348

2017
C-Reactive Protein as a Cardiovascular Risk Factor More Than an Epiphenomenon?

Wim K. Lagrand , Cees A. Visser , Willem T. Hermens , Hans W. M. Niessen
Circulation 100 ( 1) 96 -102

705
1999
Administration of C1 Inhibitor Reduces Neutrophil Activation in Patients with Sepsis

Walter A. Wuillemin , Sacha Zeerleder , Christoph Caliezi , Gerard van Mierlo
Clinical and Vaccine Immunology 10 ( 4) 529 -535

92
2003
Interleukin‐2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia

Johanna W. Baars , Jan Paul Boer , John Wagstaff , Dorina Roem
British Journal of Haematology 82 ( 2) 295 -301

48
1992
Thalidomide Inhibits Granulocyte Responses in Healthy Humans after Ex Vivo Stimulation with Bacterial Antigens

Nicole P. Juffermans , Annelies Verbon , Marc J. Schultz , C. Erik Hack
Antimicrobial Agents and Chemotherapy 45 ( 5) 1547 -1549

13
2001
PIRCHE-II is related to graft failure after kidney transplantation

Kirsten Geneugelijk , Matthias Niemann , Julia Drylewicz , Arjan D. van Zuilen
Frontiers in Immunology 9 321 -321

23
2018
History, biological mechanisms of action and clinical indications of intravenous immunoglobulin (IVIG) preparations

Jessica L. Teeling , Wim K. Bleeker , C. Erik Hack
Reviews in Medical Microbiology 13 ( 3) 91 -100

1
2002
Inflammatory markers in AD and MCI patients with different biomarker profiles-interpretation of serum and CSF levels

Alie Schuitemaker , Miranda G. Dik , Robert Veerhuis , Philip Scheltens
Neurobiology of Aging 31 ( 9) 1655 -1655

2010
Role of Cytokines in Sepsis

C. Erik Hack , Lucien A. Aarden , Lambertus G. Thus
Advances in Immunology 66 101 -195

437
1997
73
2000
Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.

Rienk Nieuwland , René J. Berckmans , Sarah McGregor , Anita N. Böing
Blood 95 ( 3) 930 -935

492
2000
Extracellular granzyme A, complexed to proteoglycans, is protected against inactivation by protease inhibitors

Elisabeth H. A. Spaeny-Dekking , Angela M. Kamp , Christopher J. Froelich , C. Erik Hack
Blood 95 ( 4) 1465 -1472

43
2000
Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma

Cornelia M. Tschopp , Nicole Spiegl , Svetlana Didichenko , Werner Lutmann
Blood 108 ( 7) 2290 -2299

128
2006
The Coagulation System in Sepsis

C. Erik Hack
The Sepsis Text 687 -704

1
2002
The role of the innate immune response in hospital- versus community-acquired infection in febrile medical patients.

A.B. Johan Groeneveld , C. Erik Hack
International Journal of Infectious Diseases 12 ( 6) 660 -670

7
2008